Clinical Trial Update: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TQ-B3101 capsules in subjects with advanced malignant tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor

Drugs mentioned

• TQ-B3101 capsules

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Malignant Tumor | Phase 2 | Status: UNKNOWN